Detailed information for compound 212528

Basic information

Technical information
  • TDR Targets ID: 212528
  • Name: 5-[2-tert-butyl-4-(hydroxymethyl)-5-methylphe nyl]sulfanyl-6-hydroxy-2-[2-(3-hydroxyphenyl) ethyl]-2-phenyl-3H-pyran-4-one
  • MW: 518.664 | Formula: C31H34O5S
  • H donors: 3 H acceptors: 4 LogP: 6.55 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 2
  • SMILES: OCc1cc(c(cc1C)SC1=C(O)OC(CC1=O)(CCc1cccc(c1)O)c1ccccc1)C(C)(C)C
  • InChi: 1S/C31H34O5S/c1-20-15-27(25(30(2,3)4)17-22(20)19-32)37-28-26(34)18-31(36-29(28)35,23-10-6-5-7-11-23)14-13-21-9-8-12-24(33)16-21/h5-12,15-17,32-33,35H,13-14,18-19H2,1-4H3
  • InChiKey: LFNYQBJJMYTMSM-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-[2-tert-butyl-4-(hydroxymethyl)-5-methyl-phenyl]sulfanyl-6-hydroxy-2-[2-(3-hydroxyphenyl)ethyl]-2-phenyl-3H-pyran-4-one
  • 5-[[2-tert-butyl-4-(hydroxymethyl)-5-methylphenyl]thio]-6-hydroxy-2-[2-(3-hydroxyphenyl)ethyl]-2-phenyl-3H-pyran-4-one
  • 5-[(2-tert-butyl-5-methyl-4-methylol-phenyl)thio]-6-hydroxy-2-[2-(3-hydroxyphenyl)ethyl]-2-phenyl-3H-pyran-4-one

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Human immunodeficiency virus type 1 protease Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) Get druggable targets OG5_131408 All targets in OG5_131408

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus multilocularis Chromobox protein 3 Human immunodeficiency virus type 1 protease   99 aa 95 aa 28.4 %
Candida albicans dethiobiotin synthetase Human immunodeficiency virus type 1 protease   99 aa 90 aa 22.2 %
Mycobacterium leprae Hypothetical protein Human immunodeficiency virus type 1 protease   99 aa 86 aa 27.9 %
Candida albicans dethiobiotin synthetase Human immunodeficiency virus type 1 protease   99 aa 90 aa 22.2 %
Giardia lamblia DNA-directed RNA polymerase subunit D Human immunodeficiency virus type 1 protease   99 aa 90 aa 27.8 %
Trypanosoma brucei variant surface glycoprotein (VSG), putative Human immunodeficiency virus type 1 protease   99 aa 80 aa 27.5 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Human immunodeficiency virus type 1 protease   99 aa 103 aa 31.1 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Human immunodeficiency virus type 1 protease   99 aa 103 aa 31.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis geranylgeranyl transferase type I beta subunit, putative 0.1512 0.3109 0.2542
Mycobacterium tuberculosis Halimadienyl diphosphate synthase 0.1331 0.2329 0.5
Trypanosoma cruzi protein farnesyltransferase, putative 0.1512 0.3109 1
Entamoeba histolytica protein farnesyltransferase alpha subunit, putative 0.1579 0.3396 0.0417
Trichomonas vaginalis geranylgeranyl transferase type beta subunit, putative 0.1512 0.3109 0.2542
Leishmania major farnesyltransferase beta subunit 0.1512 0.3109 0.5
Trichomonas vaginalis geranylgeranyl transferase type I beta subunit, putative 0.3113 1 1
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) 0.1528 0.3176 0.0097
Echinococcus granulosus geranylgeranyl transferase type I beta subunit 0.3113 1 1
Plasmodium vivax farnesyltransferase beta subunit, putative 0.1512 0.3109 0.9155
Echinococcus multilocularis geranylgeranyl transferase type I beta subunit 0.3113 1 1
Loa Loa (eye worm) hypothetical protein 0.1579 0.3396 0.0417
Loa Loa (eye worm) prenyltransferase and squalene oxidase repeat family protein 0.3113 1 1
Schistosoma mansoni geranylgeranyl transferase type I beta subunit 0.3113 1 1
Entamoeba histolytica geranylgeranyl transferase beta subunit 0.3113 1 1
Giardia lamblia Rab geranylgeranyltransferase 0.1579 0.3396 1
Schistosoma mansoni protein farnesyltransferase alpha subunit 0.1579 0.3396 0.0417
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.1579 0.3396 0.2852
Trichomonas vaginalis type I geranylgeranyltransferase beta subunit, putative 0.1512 0.3109 0.2542
Loa Loa (eye worm) prenyltransferase alpha subunit repeat containing protein 0.1579 0.3396 0.0417
Plasmodium falciparum protein farnesyltransferase subunit alpha 0.1579 0.3396 1
Brugia malayi Protein prenyltransferase alpha subunit repeat containing protein 0.1579 0.3396 0.0417
Trichomonas vaginalis protein farnesyltransferase alpha subunit/RAB geranylgeranyl transferase alpha subunit, putative 0.1579 0.3396 0.2852
Trypanosoma cruzi protein farnesyltransferase, putative 0.1512 0.3109 1
Plasmodium vivax prenyltransferase alpha subunit, putative 0.1579 0.3396 1
Trypanosoma brucei protein farnesyltransferase beta subunit 0.1512 0.3109 1
Echinococcus granulosus protein farnesyltransferase alpha subunit 0.1579 0.3396 0.0417
Toxoplasma gondii prenyltransferase and squalene oxidase repeat-containing protein 0.1512 0.3109 1
Trichomonas vaginalis protein farnesyltransferase alpha subunit, putative 0.1579 0.3396 0.2852
Trichomonas vaginalis geranylgeranyl transferase type II beta subunit, putative 0.1512 0.3109 0.2542
Trichomonas vaginalis geranylgeranyl transferase type II beta subunit, putative 0.1512 0.3109 0.2542
Echinococcus multilocularis protein farnesyltransferase alpha subunit 0.1579 0.3396 0.0417
Schistosoma mansoni geranylgeranyl transferase type I beta subunit 0.3113 1 1
Trichomonas vaginalis geranylgeranyl transferase type II beta subunit, putative 0.1512 0.3109 0.2542

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) = 6.1 uM Antiviral activity in HIV infected CEM cells. ChEMBL. 9371233
EC50 (functional) = 6.1 uM Antiviral activity in HIV infected CEM cells. ChEMBL. 9371233
IC50 (binding) = 2.5 nM In vitro inhibition activity against HIV-1 protease . ChEMBL. 9371233
IC50 (binding) = 2.5 nM In vitro inhibition activity against HIV-1 protease . ChEMBL. 9371233
TC50 (ADMET) > 100 uM Cytotoxicity in CEM cells in the absence of virus ChEMBL. 9371233
TC50 (ADMET) > 100 uM Cytotoxicity in CEM cells in the absence of virus ChEMBL. 9371233

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 9371233

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.